Spectrum Pharmaceuticals Receives CRL from FDA for EVOMELA for Injection

By: via Benzinga
Spectrum Pharmaceuticals (Nasdaq: SPPI) announced today that it has received a Complete Response Letter from the U.S. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.